Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Ivermectin Lotion 0.5% for Head Lice
NCT03257943Phase 1Completed
- Start
- Mar 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ivermectin in pediculosis capitis (3 arms). Primary endpoint: Demonstration of Bioequivalence in proportion of index subjects who are lice free at Day 15. Started Mar 2017; status: completed.
02
Drugs
ivermectin
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT03257943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03257943.